Tolerability and Pharmacokinetics Study of TQB3702 Tablets in Hematologic Tumor Subjects
Clinical trial NCT05610202 · UNKNOWN
Trial details
- NCT number
- NCT05610202
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-01
- Primary completion
- 2024-08-01
- Enrollment
- 137
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.